Nasal spray shows promise for fast hive relief in small study
NCT ID NCT05496465
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 14 times
Summary
This study tested a single dose of a nasal spray (ARS-1) to see if it can quickly reduce itching and hives in adults who have frequent flare-ups. Twenty-one participants received either the spray or a placebo, then crossed over to the other option. The main goal was to measure how fast and how long the spray worked based on patient-reported itch and hive scores.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bernstein Clinical Research Center, LLC
Cincinnati, Ohio, 45236, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.